Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 59051-59100 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT04115514
Treatment of ARDS With Instilled T3
PHASE2Recruiting
68 participants
Started: Mar 30, 2020 · Completed: Oct 31, 2026
5 conditions1 sponsor2 locations
NCT04363008
Investigating the Role of Biomarkers in Predicting Outcome for COVID 19
N/ARecruiting
150 participants
Started: Mar 30, 2020 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT04256018
Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
PHASE2Recruiting
30 participants
Started: Mar 30, 2020 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04303988
A Phase II Study of Triple-negative Breast Cancer Brain Metastases.
PHASE2Recruiting
35 participants
Started: Mar 30, 2020 · Completed: May 30, 2025
1 condition1 sponsor1 location
NCT05848427
The LUSZ COVID-19 Severity Index: A Prognostic and Predictive Score of Mortality for Hospitalized Patients With Covid-19
N/ARecruiting
1,000 participants
Started: Mar 28, 2020 · Completed: Dec 30, 2025
1 condition2 sponsors2 locations
NCT05925140
LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients
PHASE1Recruiting
1,000 participants
Started: Mar 28, 2020 · Completed: Dec 30, 2025
2 conditions2 sponsors2 locations
NCT04290000
Collection of Biological Samples From Patients Treated With CAR-T Cells for Hematological Malignancies
N/ARecruiting
300 participants
Started: Mar 27, 2020 · Completed: Mar 27, 2040
1 condition1 sponsor1 location
NCT04327570
In-depth Immunological Investigation of COVID-19.
N/ARecruiting
100 participants
Started: Mar 27, 2020 · Completed: Mar 30, 2026
1 condition1 sponsor1 location
NCT04215731
Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer
PHASE3Recruiting
500 participants
Started: Mar 27, 2020 · Completed: Feb 1, 2026
1 condition1 sponsor1 location
NCT04320732
Risk Factors for Community- and Workplace Transmission of COVID-19
N/ARecruiting
250,000 participants
Started: Mar 27, 2020 · Completed: Mar 20, 2030
1 condition2 sponsors1 location
NCT03891888
Intramedullary Bone Grafting for Open Tibial Shaft Fractures
NARecruiting
130 participants
Started: Mar 26, 2020 · Completed: Feb 28, 2025
3 conditions1 sponsor2 locations
NCT04448145
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
N/ARecruiting
800 participants
Started: Mar 26, 2020 · Completed: Oct 31, 2025
3 conditions1 sponsor1 location
NCT04064086
Trial to Evaluate and Assess the Effect of Comprehensive Pre-ESKD Education on Home Dialysis Use in Veterans
NARecruiting
544 participants
Started: Mar 25, 2020 · Completed: Sep 30, 2026
4 conditions1 sponsor1 location
NCT04305834
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
PHASE2Recruiting
43 participants
Started: Mar 25, 2020 · Completed: Aug 21, 2026
4 conditions2 sponsors3 locations
NCT05769140
Measurement of Cardiopulmonary Variables After Acute Exposure to High Altitude
N/ARecruiting
8,000 participants
Started: Mar 25, 2020 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04330742
The Effect of Fluids on Aortic VTI During C-section
N/ARecruiting
50 participants
Started: Mar 25, 2020 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT04336020
The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) Study
N/ARecruiting
100,000 participants
Started: Mar 24, 2020 · Completed: Apr 30, 2025
2 conditions2 sponsors1 location
NCT04322578
Crizotinb or Standard Chemotherapy in Met Exon 14 Skipping Advanced NSCLC
PHASE2Recruiting
120 participants
Started: Mar 24, 2020 · Completed: Mar 24, 2026
1 condition1 sponsor1 location
NCT04324164
Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC
N/ARecruiting
800 participants
Started: Mar 24, 2020 · Completed: Dec 24, 2027
1 condition1 sponsor1 location
NCT04322617
Anlotinib Plus Immune Checkpoint Inhibitors for Lung Cancer
PHASE2/PHASE3Recruiting
1,200 participants
Started: Mar 24, 2020 · Completed: Mar 24, 2029
1 condition1 sponsor1 location
NCT04324151
Pembrolizumab Combined With Double Platinum Based Chemotherapy for Potentially Resectable NSCLC
N/ARecruiting
70 participants
Started: Mar 24, 2020 · Completed: Mar 24, 2025
1 condition1 sponsor1 location
NCT04324125
Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC
N/ARecruiting
70 participants
Started: Mar 24, 2020 · Completed: Mar 24, 2025
1 condition1 sponsor1 location
NCT04322591
Chemotherapy or Chemotherapy Plus PD-1 Antibody in RET Fusion Positive Advanced NSCLC Patitnts: the POSEIDON Trial
N/ARecruiting
70 participants
Started: Mar 24, 2020 · Completed: Mar 24, 2025
1 condition1 sponsor1 location
NCT04138628
Treatment Of Metastatic Bladder Cancer at the Time Of Biochemical reLApse Following Radical Cystectomy
PHASE2Recruiting
282 participants
Started: Mar 24, 2020 · Completed: Nov 1, 2029
2 conditions6 sponsors5 locations
NCT04282187
Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
PHASE2Recruiting
25 participants
Started: Mar 24, 2020 · Completed: Nov 11, 2026
9 conditions1 sponsor1 location
NCT05588024
International Device Assisted Controlled Sequential Elevation CPR Registry
N/ARecruiting
5,000 participants
Started: Mar 23, 2020 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT05054296
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring
PHASE2Recruiting
200 participants
Started: Mar 23, 2020 · Completed: Feb 2, 2027
5 conditions2 sponsors1 location
NCT05321758
Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease
NARecruiting
50 participants
Started: Mar 22, 2020 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT04344912
Impact of COVID19 Outbreak in Cardiac Acute Care
N/ARecruiting
500 participants
Started: Mar 20, 2020 · Completed: Dec 31, 2024
3 conditions2 sponsors1 location
NCT04841447
Membrane Target Detection for Leukemia Treatment
N/ARecruiting
50 participants
Started: Mar 20, 2020 · Completed: Mar 20, 2026
1 condition1 sponsor1 location
NCT04373720
MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas
NARecruiting
80 participants
Started: Mar 20, 2020 · Completed: Nov 1, 2028
1 condition2 sponsors1 location
NCT04318366
COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor
N/ARecruiting
6,000 participants
Started: Mar 19, 2020 · Completed: Mar 19, 2026
1 condition1 sponsor13 locations
NCT04342429
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
NARecruiting
30 participants
Started: Mar 19, 2020 · Completed: May 27, 2027
1 condition1 sponsor1 location
NCT07030686
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
N/ARecruiting
1,000 participants
Started: Mar 19, 2020 · Completed: Mar 19, 2026
5 conditions1 sponsor1 location
NCT04381936
Randomised Evaluation of COVID-19 Therapy
PHASE3Recruiting
70,000 participants
Started: Mar 19, 2020 · Completed: Jun 30, 2036
1 condition10 sponsors7 locations
NCT06815159
Tissue Markers Predictive of Early Stenosis in the Arterovenous Fistula for Hemodialysis
NARecruiting
150 participants
Started: Mar 18, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04738188
Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;
NARecruiting
226 participants
Started: Mar 18, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04956445
Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasure Development
N/ARecruiting
2,000 participants
Started: Mar 17, 2020 · Completed: Mar 31, 2025
1 condition3 sponsors2 locations
NCT04233749
The Efficacy of Tranexamic Acid in the Treatment of Lichen Planus Pigmentosus and Erythema Dyschromicum Perstans
PHASE2Recruiting
5 participants
Started: Mar 17, 2020 · Completed: Dec 30, 2025
3 conditions1 sponsor1 location
NCT03804944
Converting HR+ Breast Cancer Into an Individualized Vaccine
PHASE2Recruiting
100 participants
Started: Mar 17, 2020 · Completed: Dec 31, 2027
1 condition4 sponsors8 locations
NCT04023019
Treatment of Hemophilia A Patients With FVIII Inhibitors
N/ARecruiting
120 participants
Started: Mar 17, 2020 · Completed: Jun 30, 2029
1 condition2 sponsors2 locations
NCT04170491
EEG Monitoring for Refractory Status Epilepticus
NARecruiting
40 participants
Started: Mar 17, 2020 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT05490901
The Prognostic Role and Diagnostic Efficacy of Exercise Right Heart Catheterization With a Simultaneous Echocardiography in Patients With Dyspnea on Exertion
N/ARecruiting
400 participants
Started: Mar 17, 2020 · Completed: Jun 30, 2029
2 conditions1 sponsor1 location
NCT04314323
National Registry of IRPF in China
N/ARecruiting
500 participants
Started: Mar 17, 2020 · Completed: Mar 31, 2030
1 condition1 sponsor1 location
NCT04522765
Diurnal BP Patterns in Those at Increased Risk of CVD
N/ARecruiting
120 participants
Started: Mar 17, 2020 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT04404062
Serological and PCR Testing for COVID-19
N/ARecruiting
2,500 participants
Started: Mar 16, 2020 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT04459689
COVID-19 in PID Survey
N/ARecruiting
200 participants
Started: Mar 15, 2020 · Completed: Feb 18, 2027
2 conditions1 sponsor1 location
NCT03136094
Suicide in Urban Natives: Detection and Networks to Combat Events
NARecruiting
698 participants
Started: Mar 15, 2020 · Completed: May 31, 2025
1 condition4 sponsors1 location
NCT05550077
Optical Coherence Tomography for Intracranial Atherosclerotic Stenosis
N/ARecruiting
400 participants
Started: Mar 15, 2020 · Completed: Dec 31, 2027
5 conditions1 sponsor1 location
NCT06342440
Early Detection of Advanced Adenomas and Colorectal Cancer
N/ARecruiting
2,000 participants
Started: Mar 15, 2020 · Completed: Jun 18, 2026
18 conditions1 sponsor6 locations